Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas
Baylor College of Medicine
Baylor College of Medicine
National Cancer Centre, Singapore
University of California, San Diego
University of Texas Southwestern Medical Center
University of Miami
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center